纤溶酶用于糖尿病与非糖尿病性脑梗死的效果分析

Effect of plasmin on diabetes mellitus and non diabetic cerebral infarction

目的:分析糖尿病与非糖尿病性脑梗死患者利用纤溶酶治疗的效果。方法:随机选择接受治疗的脑梗死患者84例参与研究,根据是否伴有糖尿病分成糖尿病性脑梗死与非糖尿病性脑梗死两组,均接受纤溶酶治疗,比较两组效果。结果:糖尿病性脑梗死组治疗总有效率为92.76%,非糖尿病性脑梗死组为71.43%;两组治疗前后纤维蛋白原以及血脂TC、TG水平差距不明显。结论:纤溶酶对糖尿病性脑梗死患者的治疗效果更明显,能够改善血纤维蛋白原以及血脂水平,值得推广。

Objective:To analyze the diabetic and non diabetic patients with cerebral infarction by plasmintreatment effect.Methods:the treatment of84patients with cerebral infarction were randomly selected to participatein the study received in hospital,according to whether patients with diabetes were divided into diabetic cerebralinfarction and2non-diabetic cerebral infarction group,were treated with fibrinolytic treatment,effect of two groupswere compared.Results:diabetic cerebral infarction group total effective rate was92.76%,non diabetic cerebralinfarction group was71.43%;fibrinogen and blood lipid TC in two groups before and after treatment,TG level gapis not obvious.Conclusion:the therapeutic effect of plasmin on diabetic cerebral infarction is more obvious,canimprove blood fibrinogen and blood lipid levels,worthy of promotion.